BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6820192)

  • 1. [Prophylactic controlled trials with cotrimoxazole in afebrile neutropenic patients with malignant hemopathies].
    Scaglione C; Tormena AM; Pavlovsky S
    Sangre (Barc); 1982; 27(5):912-8. PubMed ID: 6820192
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of infections in granulocytopenia patients with a brulamycin-bactrim combination].
    Magyar T; Graber H; Arr M; Csiba A; Kelemen E; Péterfy M; Jánossa M
    Orv Hetil; 1985 Sep; 126(35):2165-8. PubMed ID: 3875821
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
    Zinner SH
    Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
    Malarme M; Meunier-Carpentier F; Klastersky J
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of febrile episodes in neutropenic patients.
    Melikian V; Falk R
    Scott Med J; 1976 Apr; 21(2):73-4. PubMed ID: 940999
    [No Abstract]   [Full Text] [Related]  

  • 6. [Limitations of selective decontamination of the digestive system in granulopenia patients toward the prevention of infection].
    van der Waaij D
    Ned Tijdschr Geneeskd; 1985 Jul; 129(27):1268-9. PubMed ID: 3929148
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
    J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic administration of antimicrobiological agents and reflection thereon--prevention of infections in hematologic diseases and malignancies].
    Funada H
    Nihon Rinsho; 1986 Apr; 44(4):925-9. PubMed ID: 3093732
    [No Abstract]   [Full Text] [Related]  

  • 9. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics.
    Wolff LJ
    Am J Pediatr Hematol Oncol; 1984; 6(3):267-76. PubMed ID: 6393790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients.
    Lindemulder S; Albano E
    Pediatrics; 2007 Jul; 120(1):e47-51. PubMed ID: 17606548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing infection in neutropenic cancer patients.
    Beutler SM; Barth NM; Bayer AS
    West J Med; 1983 May; 138(5):690-8. PubMed ID: 6880186
    [No Abstract]   [Full Text] [Related]  

  • 12. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.
    Cohen J; Donnelly JP; Worsley AM; Catovsky D; Goldman JM; Galton DA
    Lancet; 1983 Dec 24-31; 2(8365-66):1452-4. PubMed ID: 6140545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
    Braine HG; Stuart RK; Saral R; Lietman PS
    Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
    Marty M; Gisselbrecht C; Samson-Lepors MJ
    Nouv Presse Med; 1979 Oct; 8(42):3465-8. PubMed ID: 537897
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of postoperative chest infection by prophylactic cotrimoxazole.
    McCollum CN
    Br J Surg; 1981 Jan; 68(1):67. PubMed ID: 6970058
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
    Verhoef J; Rozenberg-Arska M; Dekker A
    Haematol Blood Transfus; 1987; 30():188-93. PubMed ID: 3114058
    [No Abstract]   [Full Text] [Related]  

  • 17. [The prophylactic effect of trimethoprim-sulfamethoxazole against infection among children with acute leukemia].
    Inoue M; Arai S; Kamiya H; Sakurai M; Izawa T; Yamakawa T; Kamiya K; Nishimura Y; Kato T; Hiratani Y; Akatuka J; Hirotu T
    Rinsho Ketsueki; 1983 Jan; 24(1):26-33. PubMed ID: 6405064
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of the tobramycin - cotrimoxazole - cephalothin combination for febrile episodes in leukemic patients with granulocytopenia.
    Mozzana R; Cortelezzi A; Radaelli F; Polli EE
    Haematologica; 1981 Oct; 66(5):634-44. PubMed ID: 6796472
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
    Bow EJ; Rayner E; Scott BA; Louie TJ
    Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute bronchitis and trimethoprim-sulfamethoxazole.
    Flynn SP
    J Fam Pract; 1986 Nov; 23(5):428. PubMed ID: 3490537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.